Low-dose antithymocyte globulin enhanced the efficacy of tacrolimus and mycophenolate for GVHD prophylaxis in recipients of unrelated SCT

We performed a retrospective analysis of the outcome of 197 consecutive unrelated donor transplant recipients who received GVHD prophylaxis either TM regimen (tacrolimus and mycophenolate) (121 patients) or TM/ATG-G regimen (TM with low-dose antithymocyte globulin (ATG) of 4.5 mg/kg, ATG-G, Genzyme)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Bone Marrow Transplant
Main Authors: Ratanatharathorn, V, Deol, A, Ayash, L, Cronin, S, Bhutani, D, Lum, LG, Abidi, M, Ventimiglia, M, Mellert, K, Uberti, JP
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4286438/
https://ncbi.nlm.nih.gov/pubmed/25285804
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2014.203
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados